CoChat

Ketamine for a Boost of Neural Plasticity: How, but Also When?

Open access
Wu, Hao, Savalia, Neil K., Kwan, Alex C. · 2021 · Biological Psychiatry
Cited by 45

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Major depressive disorder affects millions of people and leads to debilitating symptoms. Although conventional antidepressants have been available and are often beneficial, they have several limitations, including a slow onset of action and an inadequate response for a substantial fraction of patients. Recently, ketamine—primarily a noncompetitive NMDA receptor antagonist, among other actions—was approved as a novel treatment for treatment-resistant depression and suicidal ideation. This was an exciting development because ketamine can relieve depressive symptoms rapidly and with sustained effect. What is the biological basis for ketamine’s rapid antidepressant action? One framework gaining empirical support is that ketamine promotes neural plasticity. Specifically, ketamine appears to promote synaptogenesis in brain regions such as the medial frontal cortex and hippocampus, countering the dendritic atrophy and synapse loss associated with chronic stress and depression. This framework is supported by several studies showing that a single dose of ketamine increases the number of dendritic spines (1) by elevating their formation rate in the frontal cortex (2,3). Still unclear, though, is when and how the plasticity is boosted. Specifically, when does ketamine enhance the propensity for neural plasticity—so far, studies have looked only at synaptic connections, which is the final link in the chain of events. Moreover, how does ketamine enable neural plasticity? The full complement of molecular and cellular factors remains to be elucidated. Knowledge of both the timing and mechanisms underlying ketamine’s plasticity-promoting potential will be key to harnessing fast-acting antidepressants. In the current issue of Biological Psychiatry, Wu et al. (4) present compelling data to define a time window for ketamine’s plasticity potential and uncover dopamine as a crucial component of the mechanism. Previous studies have provided clues into the time scale of ketamine’s effect on neural plasticity. In one longitudinal twophoton imaging study, a single dose of ketamine increased dendritic spine density in the medial frontal cortex within a day (2). Another recent study indicated that ketamine begins to reverse stress-induced dendritic spine loss within 12 hours of drug administration but not before 6 hours (3). Intriguingly, blocking the plasticity actions of ketamine abolished its effect on motivated escape behavior in a mouse model, suggesting that sustained antidepressant actions require neural plasticity in the medial frontal cortex (3). Together, these previous studies underscored the importance of dendritic structural remodeling for ketamine’s fast-acting antidepressant response. Still, a critical question remained: What is the time window in which ketamine engages neural plasticity to facilitate the behavioral improvements?

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2021.03.014

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 45

Metadata

Authors
Wu, H., Savalia, N. K., & Kwan, A. C.
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2021-06
Volume
89
Issue
11
Pages
1030-1032
ISSN
0006-3223 (ISSN-L)
OpenAlex
W3160529998
Cited by
45
References
8
FWCI
2.01
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ketamine for a Boost of Neural Plasticity: How, but Also When? https://app.cochat.ai/papers/10.1016/j.biopsych.2021.03.014
The paper
Wu, H., Savalia, N. K., & Kwan, A. C. (2021). Ketamine for a Boost of Neural Plasticity: How, but Also When? Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2021.03.014

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.